1. <tr id="bfkjl"></tr>
    <ins id="bfkjl"><video id="bfkjl"><optgroup id="bfkjl"></optgroup></video></ins>

        Urofollitropin
        CAS No.: 97048-13-0 (Follicle-stimulating hormone)

        Short Description:

        Source: Extracted from the urine of menopausal women
        Function and use: Stimulate the proliferation and differentiation of granulosa cells, induce the synthesis of granulosa cell receptors, and bind to the receptors, activate the activity of enzymes in the body, promote the transformation between hormones, regulate the growth and development of human organs, sexual maturation and reproductive activities A series of related physiological processes. Regulates the menstrual cycle of women to promote follicular development and ovulation in women, regulates testicular function and gonadotropin secretion in men, and treats male infertility; it is clinically used for in vitro reproductive assistance.

        Urofollitropin-Pharmacopoeia?Standard:?BP/EP


        Product Detail

        Product Tags

        Specification

        Urofollitropin
        Source urine of menopausal women

        Standard

        NMPA

        BP/EP

        Definition

        This product is the gonadotropin extracted from the urine of postmenopausal women, which is freeze-dried with lactose as excipient.?It mainly contains follicle stimulating hormone (FSH), and almost does not contain luteinizing hormone (LH).

        Dried preparation containing menopausal gonadotrophin obtained from the urine of post-menopausal women. It has follicle-stimulating activity and no or

        virtually no luteinising activity.

        Production

        It is prepared by suitable collection and extraction procedures followed by purification steps. The method of preparation includes steps that have been shown to remove and/or inactivate extraneous agents. In addition, the process is designed to minimise microbial contamination.

        Character

        White or almost white powder.

        Soluble in water.

        Almost white or slightly yellowish powder.

        Soluble in water.

        Identification

        When administered to immature female rats as prescribed in the assay, it causes significantly enlargement of the ovaries of young female rats

        When administered to immature female rats as prescribed in the assay, it causes enlargement of the ovaries.

        Test

        Water

        Maximum 5.0 per cent

        Maximum 5.0 per cent

        Residual solvent

        Not more than 0.5%

        _______

        Bacterial endotoxins

        Less than 0.01EU per IU of FSH

        Less than 0.40EU per IU of FSH

        PH

        5.5-7.0

        _______

        Appearance of solution

        The solution is clear and colorless

        _______

        Abnormal endotoxin

        All the animals survive for 48 hours.

        _______

        potency

        FSH

        Not less than 200IU/mg

        Not less than 90IU/mg

        Specific activity

        More than 8500IU/mg.pr

        _______

        Residual luteinising activity

        LH/FSH should be N.M.T 1/60

        LH/FSH should be N.M.T 1/60

        Microbial limit

        TAMC

        ≤102cfu/750IU

        _______

        TYMC

        ≤101cfu/750IU

        _______

        Escherichia coli

        Should not be detected

        _______
        Virus

        Hbs Ag

        Should be negative

        _______

        HCV antibodies

        Should be negative

        _______

        HIV I+II

        Should be negative

        _______

        Storage

        In an airtight container, protected from light, at a temperature of 2 °C to 8 °C.

        In an airtight container, protected from light, at a temperature of 2 °C to 8 °C.

        Category

        Gonadotropins

        Preparation

        Urofollitropin for injection

        Indications

        1. It is mainly used in combination with chorionic gonadotropin for anovulatory infertility caused by insufficient gonadotropin secretion (hypothalamic pituitary dysfunction or disharmony). It is generally recommended to be used in cases of ineffective ovulation induction such as clomiphene (CC) or bromocriptine.

        2. Combined with chorionic gonadotropin, it is used for the treatment of primary or secondary amenorrhea and ovarian function test.

        3. It is used for polycystic ovary syndrome (PCOS), especially for those who are ineffective with clomiphene.

        4. In the assisted pregnancy technology, the stimulation of superovulation in normal ovulating women is often used in combination with clomiphene and chorionic gonadotropin to obtain multiple eggs at a time.

        5. Combined with chorionic gonadotropin to treat male hypogonadism and infertility, and stimulate spermatogenic function.


      1. Previous:
      2. Next:

      3. Write your message here and send it to us
        玩弄少妇高潮A片_国产女人AAA级久久久级_亚洲国产欧美一区三区成人_国产乱色国产精品免费视频

        1. <tr id="bfkjl"></tr>
          <ins id="bfkjl"><video id="bfkjl"><optgroup id="bfkjl"></optgroup></video></ins>